The Register · A provider
Central Institute of Mental Health (ZI Mannheim)
Mannheim, Germany · Germany
Specialties
Reports that name this provider
- Clinical Trial Access in Germany
- Hosts EU's first psilocybin compassionate use program for treatment-resistant depression, approved July 2025, in partnership with Filament Health
- Medication Availability in Germany
- Licensed to administer psilocybin under compassionate use program for treatment-resistant depression since July 2025